Cite
HARVARD Citation
Venkatakrishnan, K. et al. (n.d.). Dose selection for the investigational anticancer agent alisertib (MLN8237): Pharmacokinetics, pharmacodynamics, and exposure–safety relationships. Journal of clinical pharmacology. pp. 336-347. [Online].